*University of Massachusetts Medical School, Worcester, MA;
†Boston University School of Medicine, Boston, MA;
‡University of North Carolina at Chapel Hill, Chapel Hill, NC.
Address for reprints: Jean A. Frazier, MD, University of Massachusetts Medical School, 55 Lake Avenue, North, Worcester, MA 01655; e-mail: [email protected].
This study was supported by The National Institute of Neurological Disorders and Stroke (5U01NS040069-05; 2R01NS040069-06A2), and the National Institute of Child Health and Human Development (5R01HD092374-02 and 5P30HD018655-34), and the Office of the National Institutes of Health Director (1UG3OD023348-01).
Disclosure: J. A. Frazier has the following disclosures: receiving research support from Takeda Pharmaceuticals, Fulcrum Therapeutics, Janssen Research and Development, and Roche. No funds from these entities supported this project, and none of these entities reviewed/commented on this study. The remaining authors declare no conflict of interest.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jdbp.org).